Moneycontrol PRO
HomeNewsTrendsMan tests positive for Monkeypox, Covid-19 and HIV after Spain trip

Man tests positive for Monkeypox, Covid-19 and HIV after Spain trip

The 36-year-old man, who has not been identified, developed a sore throat, fever, headache and fatigue after returning to Italy

August 25, 2022 / 17:43 IST

An Italian man has tested positive for Covid-19, Monkeypox and HIV at the same time after a trip to Spain. The first of its kind case of co-infection was reported in the Journal of Infection earlier this month.

The 36-year-old man, who has not been identified, developed a sore throat, fever, headache and fatigue after returning to Italy from his Spanish trip. The man had visited Spain for a five-day trip between June 16 and June 20, during which he engaged in unprotected sex.

All the symptoms appeared nine days after he returned from his trip. A few days later, on July 2, he tested positive for Covid-19.

On the same day, he also noticed small, painful vesicles surrounded by a rash had begun developing on his torso, arms, face and glutes. The vesicles soon grew into painful pustules and, on July 5, the man visited the emergency department at the University Hospital in Catania.

There, he was referred to the infectious disease unit and tested positive for Monkeypox.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

The man was also screened for sexually transmitted diseases and his test came back positive for HIV. Doctors said the “infection was relatively recent” and a HIV test he performed in September 2021 had returned negative.

"This case highlights how monkeypox and COVID-19 symptoms may overlap, and corroborates how in case of co-infection, anamnestic collection and sexual habits are crucial to perform the correct diagnosis," researchers said in the study published in the Journal of Infection.

The man has since recovered from Covid-19 and Monkeypox.

Moneycontrol News
first published: Aug 25, 2022 05:42 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347